Cargando…
Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
The coronavirus disease 2019 (COVID-19) pandemic has brought increased attention to vulnerable populations such as older or immunocompromised patients and heightened the focus on alternatives to intravenous (IV) formulations, particularly those that may be administered in a non-clinical setting. Amo...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439384/ https://www.ncbi.nlm.nih.gov/pubmed/34531668 http://dx.doi.org/10.2147/CEOR.S317687 |